Company: BIVIW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001520138-25-000343
Chunk: 1

Company: BIOVIE INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
,224 shares are outstanding at June 30, 2025 
     754  
     192 
  
    Additional paid in capital 
     382,195,626  
     371,156,068 
  
    Accumulated deficit 
     (357,275,347) 
     (352,144,246)
  
    Treasury stock 
     (29) 
     (29)
  
    Total stockholders' equity 
     24,921,004  
     19,011,985 

    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 
    $26,820,098  
    $21,562,199 

See accompanying notes to unaudited condensed financial
statements

4

Table of Contents 

BioVie Inc.

Condensed Statements of Operations 

(Unaudited)

    Three Months Ended  
    Three Months Ended 

    September 30, 2025  
    September 30, 2024 

    OPERATING EXPENSES: 

    Amortization of intangible assets 
    $57,344  
    $57,344 
  
    Research and development expenses 
     2,936,370  
     1,990,198 
  
    General and administrative expenses 
     2,290,881  
     2,074,540 
  
    TOTAL OPERATING EXPENSES 
     5,284,595  
     4,122,082 

    LOSS FROM OPERATIONS 
     (5,284,595) 
     (4,122,082)

    OTHER (INCOME) EXPENSE: 

    Change in fair value of derivative liabilities 
     -  
     (2,517)
  
    Interest expense 
     1,989  
     256,024 
  
    Interest income 
     (199,027) 
     (223,557)
  
    TOTAL OTHER (INCOME) EXPENSE, NET 
     (197,038) 
     29,950 

    NET LOSS 
    $(5,087,557) 
    $(4,152,032)

    Deemed dividend related to ratchet adjustment to warrants 
     43,544  
     325,041 

    NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS 
    $(5,131,101)